Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lisa Lubsch

2PUBLICATIONS

4CO-AUTHORS

Liquid biopsiesContract law

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Dec 01, 2021

The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.

Hunter Ragan, Elizabeth Autry, Taryn Bomersback

|Sep 09, 2021

Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis.

Ashlee Anderson, Lindsey McCoy, Rebecca S Pettit

Pageof 1

Frequent Collaborators

1 joint publications

Ashlee Anderson

1 joint publications

Rebecca S Pettit

1 joint publications

Brittany A Wright

1 joint publications

Elizabeth Autry

Frequent Collaborators

1 joint publications

Ashlee Anderson

1 joint publications

Rebecca S Pettit

1 joint publications

Brittany A Wright

1 joint publications

Elizabeth Autry

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos